{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T04:22:29Z","timestamp":1743394949376,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10554-019-01756-w","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T07:02:53Z","timestamp":1577948573000},"page":"565-575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The influence of implantation techniques on lesion oriented-outcomes in Absorb BVS and Xience EES lesions treated in routine clinical practice at complete three year follow-up: AIDA trial QCA substudy"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5739-2373","authenticated-orcid":false,"given":"Ruben Y. G.","family":"Tijssen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura S. M.","family":"Kerkmeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Kogame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Katagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin P.","family":"Kraak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ply","family":"Chichareon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Modolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Nassif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah N.","family":"Kalkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Sotomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Collet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoerd H.","family":"Hofma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene J.","family":"van der Schaaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Karin","family":"Arkenbout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auke P. J. D.","family":"Weevers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan J.","family":"Piek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan G. P.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose P.","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robbert J.","family":"de Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna J.","family":"Wykrzykowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"issue":"1","key":"1756_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/eurheartj\/ehr384","volume":"33","author":"PW Serruys","year":"2012","unstructured":"Serruys PW, Garcia-Garcia HM, Onuma Y (2012) From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J 33(1):16\u201325b","journal-title":"Eur Heart J"},{"issue":"10096","key":"1756_CR2","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0140-6736(17)31470-8","volume":"390","author":"ZA Ali","year":"2017","unstructured":"Ali ZA, Serruys PW, Kimura T et al (2017) 2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. Lancet 390(10096):760\u2013772","journal-title":"Lancet"},{"issue":"10059","key":"1756_CR3","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","volume":"388","author":"PW Serruys","year":"2016","unstructured":"Serruys PW, Chevalier B, Sotomi Y et al (2016) Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet 388(10059):2479\u20132491","journal-title":"Lancet"},{"issue":"24","key":"1756_CR4","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","volume":"376","author":"JJ Wykrzykowska","year":"2017","unstructured":"Wykrzykowska JJ, Kraak RP, Hofma SH et al (2017) Bioresorbable scaffolds versus metallic stents in routine PCI. N Engl J Med. 376(24):2319\u20132328","journal-title":"N Engl J Med."},{"issue":"1","key":"1756_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4244\/EIJY15M02_03","volume":"11","author":"JA Ormiston","year":"2015","unstructured":"Ormiston JA, Webber B, Ubod B et al (2015) An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8\/Xpedition). EuroIntervention 11(1):60\u201367","journal-title":"EuroIntervention"},{"issue":"8","key":"1756_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jacc.2015.12.019","volume":"67","author":"S Puricel","year":"2016","unstructured":"Puricel S, Cuculi F, Weissner M et al (2016) Bioresorbable coronary scaffold thrombosis: multicenter comprehensive analysis of clinical presentation, mechanisms, and predictors. J Am Coll Cardiol 67(8):921\u2013931","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1756_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jcin.2016.03.027","volume":"9","author":"P Suwannasom","year":"2016","unstructured":"Suwannasom P, Sotomi Y, Ishibashi Y et al (2016) The impact of post-procedural asymmetry, expansion, and eccentricity of bioresorbable everolimus-eluting scaffold and metallic everolimus-eluting stent on clinical outcomes in the ABSORB II trial. JACC Cardiovasc Interv 9(12):1231\u20131242","journal-title":"JACC Cardiovasc Interv"},{"issue":"17","key":"1756_CR8","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.4244\/EIJ-D-16-00974","volume":"12","author":"L Ortega-Paz","year":"2017","unstructured":"Ortega-Paz L, Capodanno D, Gori T et al (2017) Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score. EuroIntervention 12(17):2110\u20132117","journal-title":"EuroIntervention"},{"issue":"23","key":"1756_CR9","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1016\/j.jacc.2017.09.1106","volume":"70","author":"GW Stone","year":"2017","unstructured":"Stone GW, Abizaid A, Onuma Y et al (2017) Effect of technique on outcomes following bioresorbable vascular scaffold implantation: analysis from the ABSORB trials. J Am Coll Cardiol 70(23):2863\u20132874","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1756_CR10","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.4244\/EIJ-D-17-01152","volume":"14","author":"RYG Tijssen","year":"2018","unstructured":"Tijssen RYG, Kraak RP, Elias J et al (2018) Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial. EuroIntervention 14(4):e434\u2013e442","journal-title":"EuroIntervention"},{"issue":"2","key":"1756_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ahj.2013.09.017","volume":"167","author":"P Woudstra","year":"2014","unstructured":"Woudstra P, Grundeken MJ, Kraak RP et al (2014) Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: rationale and study design. Am Heart J 167(2):133\u2013140","journal-title":"Am Heart J"},{"issue":"4","key":"1756_CR12","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.4244\/EIJ-D-18-00335","volume":"14","author":"RYG Tijssen","year":"2018","unstructured":"Tijssen RYG, Kraak RP, Hofma SH et al (2018) Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI. EuroIntervention 14(4):e426\u2013e433","journal-title":"EuroIntervention"},{"issue":"9867","key":"1756_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(13)60108-7","volume":"381","author":"V Farooq","year":"2013","unstructured":"Farooq V, van Klaveren D, Steyerberg EW et al (2013) Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 381(9867):639\u2013650","journal-title":"Lancet"},{"issue":"3","key":"1756_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10554-017-1241-9","volume":"34","author":"MI Hayiroglu","year":"2018","unstructured":"Hayiroglu MI, Keskin M, Uzun AO et al (2018) Predictive value of SYNTAX score II for clinical outcomes in cardiogenic shock underwent primary percutaneous coronary intervention; a pilot study. Int J Cardiovasc Imaging 34(3):329\u2013336","journal-title":"Int J Cardiovasc Imaging"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-019-01756-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10554-019-01756-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-019-01756-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T01:32:23Z","timestamp":1609464743000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10554-019-01756-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1756"],"URL":"https:\/\/doi.org\/10.1007\/s10554-019-01756-w","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"type":"print","value":"1569-5794"},{"type":"electronic","value":"1573-0743"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"19 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The Amsterdam UMC Heart Center received an unrestricted educational research grant from Abbott Vascular for the AIDA trial. The Research Department of the cardiology division of the Medical Center Leeuwarden received non-study related unrestricted educational research grants from Abbott Vascular. J.J. Wykrzykowska receives consultancy fees and research grants from Abbott Vascular. J.P.S Henriques receives research Grants from Abbott Vascular. J.G.P. Tijssen served on the DSMB of the early ABSORB trials, including ABSORB II. The other co-authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All patients provided written informed consent. Staged informed consent (oral followed by written consent) was allowed for urgent procedures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}